nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A2—type 2 diabetes mellitus	0.174	0.602	CbGaD
Rabeprazole—CYP3A4—type 2 diabetes mellitus	0.115	0.398	CbGaD
Rabeprazole—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0208	0.0447	CbGbCtD
Rabeprazole—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0204	0.0437	CbGbCtD
Rabeprazole—ABCG2—Glyburide—type 2 diabetes mellitus	0.0203	0.0436	CbGbCtD
Rabeprazole—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0186	0.04	CbGbCtD
Rabeprazole—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0177	0.038	CbGbCtD
Rabeprazole—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0177	0.038	CbGbCtD
Rabeprazole—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0173	0.0372	CbGbCtD
Rabeprazole—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0164	0.0351	CbGbCtD
Rabeprazole—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0158	0.0339	CbGbCtD
Rabeprazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0151	0.0324	CbGbCtD
Rabeprazole—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0147	0.0316	CbGbCtD
Rabeprazole—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0147	0.0316	CbGbCtD
Rabeprazole—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0136	0.0292	CbGbCtD
Rabeprazole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0135	0.0289	CbGbCtD
Rabeprazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0133	0.0285	CbGbCtD
Rabeprazole—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0131	0.0282	CbGbCtD
Rabeprazole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0124	0.0267	CbGbCtD
Rabeprazole—CYP2C9—Valsartan—type 2 diabetes mellitus	0.012	0.0258	CbGbCtD
Rabeprazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0119	0.0255	CbGbCtD
Rabeprazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0118	0.0254	CbGbCtD
Rabeprazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0112	0.0241	CbGbCtD
Rabeprazole—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0112	0.024	CbGbCtD
Rabeprazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0108	0.0233	CbGbCtD
Rabeprazole—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0107	0.023	CbGbCtD
Rabeprazole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0102	0.0219	CbGbCtD
Rabeprazole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00979	0.021	CbGbCtD
Rabeprazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00947	0.0203	CbGbCtD
Rabeprazole—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00907	0.0195	CbGbCtD
Rabeprazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00857	0.0184	CbGbCtD
Rabeprazole—CYP2C19—Losartan—type 2 diabetes mellitus	0.0083	0.0178	CbGbCtD
Rabeprazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.00765	0.0164	CbGbCtD
Rabeprazole—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00754	0.0162	CbGbCtD
Rabeprazole—CYP2C9—Losartan—type 2 diabetes mellitus	0.0069	0.0148	CbGbCtD
Rabeprazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00649	0.0139	CbGbCtD
Rabeprazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00622	0.0134	CbGbCtD
Rabeprazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00622	0.0134	CbGbCtD
Rabeprazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00589	0.0126	CbGbCtD
Rabeprazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00438	0.00941	CbGbCtD
Rabeprazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00401	0.00861	CbGbCtD
Rabeprazole—Omeprazole—CYP11A1—type 2 diabetes mellitus	0.000935	0.301	CrCbGaD
Rabeprazole—Pantoprazole—CYP1A2—type 2 diabetes mellitus	0.000421	0.135	CrCbGaD
Rabeprazole—Esomeprazole—CYP3A4—type 2 diabetes mellitus	0.000385	0.124	CrCbGaD
Rabeprazole—Omeprazole—CYP1A2—type 2 diabetes mellitus	0.000343	0.11	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A2—type 2 diabetes mellitus	0.000314	0.101	CrCbGaD
Rabeprazole—Pantoprazole—CYP3A4—type 2 diabetes mellitus	0.000278	0.0895	CrCbGaD
Rabeprazole—Omeprazole—CYP3A4—type 2 diabetes mellitus	0.000227	0.073	CrCbGaD
Rabeprazole—Lansoprazole—CYP3A4—type 2 diabetes mellitus	0.000208	0.0668	CrCbGaD
Rabeprazole—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.27e-05	0.000362	CcSEcCtD
Rabeprazole—Cough—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000362	CcSEcCtD
Rabeprazole—Headache—Sitagliptin—type 2 diabetes mellitus	6.26e-05	0.000361	CcSEcCtD
Rabeprazole—Anaemia—Losartan—type 2 diabetes mellitus	6.25e-05	0.00036	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000359	CcSEcCtD
Rabeprazole—Agitation—Losartan—type 2 diabetes mellitus	6.21e-05	0.000358	CcSEcCtD
Rabeprazole—Oedema—Metformin—type 2 diabetes mellitus	6.21e-05	0.000358	CcSEcCtD
Rabeprazole—Tinnitus—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000358	CcSEcCtD
Rabeprazole—Hypertension—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000358	CcSEcCtD
Rabeprazole—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.19e-05	0.000357	CcSEcCtD
Rabeprazole—Angioedema—Losartan—type 2 diabetes mellitus	6.18e-05	0.000356	CcSEcCtD
Rabeprazole—Insomnia—Valsartan—type 2 diabetes mellitus	6.17e-05	0.000356	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000354	CcSEcCtD
Rabeprazole—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.13e-05	0.000353	CcSEcCtD
Rabeprazole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.12e-05	0.000353	CcSEcCtD
Rabeprazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000353	CcSEcCtD
Rabeprazole—Chest pain—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000353	CcSEcCtD
Rabeprazole—Myalgia—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000353	CcSEcCtD
Rabeprazole—Shock—Metformin—type 2 diabetes mellitus	6.11e-05	0.000353	CcSEcCtD
Rabeprazole—Insomnia—Orlistat—type 2 diabetes mellitus	6.1e-05	0.000352	CcSEcCtD
Rabeprazole—Malaise—Losartan—type 2 diabetes mellitus	6.1e-05	0.000352	CcSEcCtD
Rabeprazole—Anxiety—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000352	CcSEcCtD
Rabeprazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.09e-05	0.000351	CcSEcCtD
Rabeprazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.08e-05	0.000351	CcSEcCtD
Rabeprazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000351	CcSEcCtD
Rabeprazole—Vertigo—Losartan—type 2 diabetes mellitus	6.07e-05	0.00035	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.07e-05	0.00035	CcSEcCtD
Rabeprazole—Somnolence—Valsartan—type 2 diabetes mellitus	6.06e-05	0.00035	CcSEcCtD
Rabeprazole—Syncope—Losartan—type 2 diabetes mellitus	6.06e-05	0.00035	CcSEcCtD
Rabeprazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.05e-05	0.000349	CcSEcCtD
Rabeprazole—Leukopenia—Losartan—type 2 diabetes mellitus	6.05e-05	0.000349	CcSEcCtD
Rabeprazole—Discomfort—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000349	CcSEcCtD
Rabeprazole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.01e-05	0.000346	CcSEcCtD
Rabeprazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.01e-05	0.000346	CcSEcCtD
Rabeprazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.98e-05	0.000345	CcSEcCtD
Rabeprazole—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000345	CcSEcCtD
Rabeprazole—Palpitations—Losartan—type 2 diabetes mellitus	5.97e-05	0.000345	CcSEcCtD
Rabeprazole—Nausea—Glimepiride—type 2 diabetes mellitus	5.96e-05	0.000344	CcSEcCtD
Rabeprazole—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000343	CcSEcCtD
Rabeprazole—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.94e-05	0.000343	CcSEcCtD
Rabeprazole—Nausea—Sitagliptin—type 2 diabetes mellitus	5.94e-05	0.000342	CcSEcCtD
Rabeprazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000342	CcSEcCtD
Rabeprazole—Asthenia—Glyburide—type 2 diabetes mellitus	5.93e-05	0.000342	CcSEcCtD
Rabeprazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.93e-05	0.000342	CcSEcCtD
Rabeprazole—Anorexia—Metformin—type 2 diabetes mellitus	5.92e-05	0.000342	CcSEcCtD
Rabeprazole—Cough—Losartan—type 2 diabetes mellitus	5.9e-05	0.00034	CcSEcCtD
Rabeprazole—Urticaria—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.00034	CcSEcCtD
Rabeprazole—Alopecia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000339	CcSEcCtD
Rabeprazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000339	CcSEcCtD
Rabeprazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000339	CcSEcCtD
Rabeprazole—Oedema—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000338	CcSEcCtD
Rabeprazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000338	CcSEcCtD
Rabeprazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.86e-05	0.000338	CcSEcCtD
Rabeprazole—Pruritus—Glyburide—type 2 diabetes mellitus	5.85e-05	0.000338	CcSEcCtD
Rabeprazole—Constipation—Valsartan—type 2 diabetes mellitus	5.83e-05	0.000337	CcSEcCtD
Rabeprazole—Hypotension—Metformin—type 2 diabetes mellitus	5.8e-05	0.000335	CcSEcCtD
Rabeprazole—Erythema—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000334	CcSEcCtD
Rabeprazole—Malnutrition—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000334	CcSEcCtD
Rabeprazole—Shock—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.000333	CcSEcCtD
Rabeprazole—Pain—Orlistat—type 2 diabetes mellitus	5.76e-05	0.000333	CcSEcCtD
Rabeprazole—Arthralgia—Losartan—type 2 diabetes mellitus	5.76e-05	0.000332	CcSEcCtD
Rabeprazole—Myalgia—Losartan—type 2 diabetes mellitus	5.76e-05	0.000332	CcSEcCtD
Rabeprazole—Chest pain—Losartan—type 2 diabetes mellitus	5.76e-05	0.000332	CcSEcCtD
Rabeprazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.75e-05	0.000332	CcSEcCtD
Rabeprazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000331	CcSEcCtD
Rabeprazole—Anxiety—Losartan—type 2 diabetes mellitus	5.74e-05	0.000331	CcSEcCtD
Rabeprazole—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.00033	CcSEcCtD
Rabeprazole—Rash—Bromocriptine—type 2 diabetes mellitus	5.7e-05	0.000329	CcSEcCtD
Rabeprazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.7e-05	0.000329	CcSEcCtD
Rabeprazole—Tension—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000328	CcSEcCtD
Rabeprazole—Discomfort—Losartan—type 2 diabetes mellitus	5.69e-05	0.000328	CcSEcCtD
Rabeprazole—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000327	CcSEcCtD
Rabeprazole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000327	CcSEcCtD
Rabeprazole—Headache—Bromocriptine—type 2 diabetes mellitus	5.67e-05	0.000327	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.66e-05	0.000327	CcSEcCtD
Rabeprazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.66e-05	0.000326	CcSEcCtD
Rabeprazole—Nervousness—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000325	CcSEcCtD
Rabeprazole—Dry mouth—Losartan—type 2 diabetes mellitus	5.63e-05	0.000325	CcSEcCtD
Rabeprazole—Anorexia—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000322	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.58e-05	0.000322	CcSEcCtD
Rabeprazole—Paraesthesia—Metformin—type 2 diabetes mellitus	5.58e-05	0.000322	CcSEcCtD
Rabeprazole—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000322	CcSEcCtD
Rabeprazole—Confusional state—Losartan—type 2 diabetes mellitus	5.56e-05	0.000321	CcSEcCtD
Rabeprazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.55e-05	0.00032	CcSEcCtD
Rabeprazole—Dyspnoea—Metformin—type 2 diabetes mellitus	5.54e-05	0.00032	CcSEcCtD
Rabeprazole—Somnolence—Metformin—type 2 diabetes mellitus	5.52e-05	0.000319	CcSEcCtD
Rabeprazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.52e-05	0.000318	CcSEcCtD
Rabeprazole—Oedema—Losartan—type 2 diabetes mellitus	5.52e-05	0.000318	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.51e-05	0.000318	CcSEcCtD
Rabeprazole—Hypotension—Irbesartan—type 2 diabetes mellitus	5.48e-05	0.000316	CcSEcCtD
Rabeprazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.47e-05	0.000316	CcSEcCtD
Rabeprazole—Dyspepsia—Metformin—type 2 diabetes mellitus	5.47e-05	0.000315	CcSEcCtD
Rabeprazole—Tremor—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000313	CcSEcCtD
Rabeprazole—Shock—Losartan—type 2 diabetes mellitus	5.43e-05	0.000313	CcSEcCtD
Rabeprazole—Urticaria—Valsartan—type 2 diabetes mellitus	5.42e-05	0.000313	CcSEcCtD
Rabeprazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.4e-05	0.000312	CcSEcCtD
Rabeprazole—Decreased appetite—Metformin—type 2 diabetes mellitus	5.4e-05	0.000312	CcSEcCtD
Rabeprazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000311	CcSEcCtD
Rabeprazole—Tachycardia—Losartan—type 2 diabetes mellitus	5.38e-05	0.000311	CcSEcCtD
Rabeprazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.38e-05	0.00031	CcSEcCtD
Rabeprazole—Nausea—Bromocriptine—type 2 diabetes mellitus	5.37e-05	0.00031	CcSEcCtD
Rabeprazole—Urticaria—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000309	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000308	CcSEcCtD
Rabeprazole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.33e-05	0.000308	CcSEcCtD
Rabeprazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000307	CcSEcCtD
Rabeprazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000307	CcSEcCtD
Rabeprazole—Asthenia—Gliclazide—type 2 diabetes mellitus	5.33e-05	0.000307	CcSEcCtD
Rabeprazole—Agitation—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000307	CcSEcCtD
Rabeprazole—Constipation—Metformin—type 2 diabetes mellitus	5.31e-05	0.000306	CcSEcCtD
Rabeprazole—Angioedema—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000306	CcSEcCtD
Rabeprazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000304	CcSEcCtD
Rabeprazole—Anorexia—Losartan—type 2 diabetes mellitus	5.26e-05	0.000303	CcSEcCtD
Rabeprazole—Vomiting—Glyburide—type 2 diabetes mellitus	5.26e-05	0.000303	CcSEcCtD
Rabeprazole—Pruritus—Gliclazide—type 2 diabetes mellitus	5.25e-05	0.000303	CcSEcCtD
Rabeprazole—Malaise—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000302	CcSEcCtD
Rabeprazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000302	CcSEcCtD
Rabeprazole—Rash—Glyburide—type 2 diabetes mellitus	5.21e-05	0.000301	CcSEcCtD
Rabeprazole—Somnolence—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000301	CcSEcCtD
Rabeprazole—Dermatitis—Glyburide—type 2 diabetes mellitus	5.21e-05	0.000301	CcSEcCtD
Rabeprazole—Vertigo—Ramipril—type 2 diabetes mellitus	5.21e-05	0.0003	CcSEcCtD
Rabeprazole—Syncope—Ramipril—type 2 diabetes mellitus	5.2e-05	0.0003	CcSEcCtD
Rabeprazole—Leukopenia—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000299	CcSEcCtD
Rabeprazole—Headache—Glyburide—type 2 diabetes mellitus	5.18e-05	0.000299	CcSEcCtD
Rabeprazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000298	CcSEcCtD
Rabeprazole—Hypotension—Losartan—type 2 diabetes mellitus	5.16e-05	0.000297	CcSEcCtD
Rabeprazole—Palpitations—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000296	CcSEcCtD
Rabeprazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.12e-05	0.000295	CcSEcCtD
Rabeprazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000294	CcSEcCtD
Rabeprazole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000294	CcSEcCtD
Rabeprazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.08e-05	0.000293	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.08e-05	0.000293	CcSEcCtD
Rabeprazole—Cough—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000292	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.03e-05	0.00029	CcSEcCtD
Rabeprazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.03e-05	0.00029	CcSEcCtD
Rabeprazole—Convulsion—Ramipril—type 2 diabetes mellitus	5.02e-05	0.00029	CcSEcCtD
Rabeprazole—Constipation—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000289	CcSEcCtD
Rabeprazole—Pain—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000289	CcSEcCtD
Rabeprazole—Insomnia—Losartan—type 2 diabetes mellitus	4.99e-05	0.000288	CcSEcCtD
Rabeprazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.97e-05	0.000287	CcSEcCtD
Rabeprazole—Paraesthesia—Losartan—type 2 diabetes mellitus	4.95e-05	0.000286	CcSEcCtD
Rabeprazole—Urticaria—Metformin—type 2 diabetes mellitus	4.94e-05	0.000285	CcSEcCtD
Rabeprazole—Arthralgia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000285	CcSEcCtD
Rabeprazole—Myalgia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000285	CcSEcCtD
Rabeprazole—Chest pain—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000285	CcSEcCtD
Rabeprazole—Dyspnoea—Losartan—type 2 diabetes mellitus	4.92e-05	0.000284	CcSEcCtD
Rabeprazole—Anxiety—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000284	CcSEcCtD
Rabeprazole—Nausea—Glyburide—type 2 diabetes mellitus	4.91e-05	0.000283	CcSEcCtD
Rabeprazole—Abdominal pain—Metformin—type 2 diabetes mellitus	4.91e-05	0.000283	CcSEcCtD
Rabeprazole—Dizziness—Gliclazide—type 2 diabetes mellitus	4.91e-05	0.000283	CcSEcCtD
Rabeprazole—Somnolence—Losartan—type 2 diabetes mellitus	4.9e-05	0.000283	CcSEcCtD
Rabeprazole—Asthenia—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000282	CcSEcCtD
Rabeprazole—Discomfort—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000281	CcSEcCtD
Rabeprazole—Dyspepsia—Losartan—type 2 diabetes mellitus	4.86e-05	0.00028	CcSEcCtD
Rabeprazole—Asthenia—Orlistat—type 2 diabetes mellitus	4.84e-05	0.000279	CcSEcCtD
Rabeprazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000279	CcSEcCtD
Rabeprazole—Pruritus—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000278	CcSEcCtD
Rabeprazole—Dry mouth—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000278	CcSEcCtD
Rabeprazole—Decreased appetite—Losartan—type 2 diabetes mellitus	4.8e-05	0.000277	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.79e-05	0.000277	CcSEcCtD
Rabeprazole—Confusional state—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000275	CcSEcCtD
Rabeprazole—Pruritus—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000275	CcSEcCtD
Rabeprazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000273	CcSEcCtD
Rabeprazole—Oedema—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000273	CcSEcCtD
Rabeprazole—Vomiting—Gliclazide—type 2 diabetes mellitus	4.72e-05	0.000272	CcSEcCtD
Rabeprazole—Constipation—Losartan—type 2 diabetes mellitus	4.72e-05	0.000272	CcSEcCtD
Rabeprazole—Pain—Losartan—type 2 diabetes mellitus	4.72e-05	0.000272	CcSEcCtD
Rabeprazole—Rash—Gliclazide—type 2 diabetes mellitus	4.68e-05	0.00027	CcSEcCtD
Rabeprazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.68e-05	0.00027	CcSEcCtD
Rabeprazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000269	CcSEcCtD
Rabeprazole—Urticaria—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000269	CcSEcCtD
Rabeprazole—Shock—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000269	CcSEcCtD
Rabeprazole—Headache—Gliclazide—type 2 diabetes mellitus	4.65e-05	0.000268	CcSEcCtD
Rabeprazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000267	CcSEcCtD
Rabeprazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000267	CcSEcCtD
Rabeprazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000267	CcSEcCtD
Rabeprazole—Tachycardia—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000266	CcSEcCtD
Rabeprazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000266	CcSEcCtD
Rabeprazole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000264	CcSEcCtD
Rabeprazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.55e-05	0.000262	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.51e-05	0.00026	CcSEcCtD
Rabeprazole—Dizziness—Valsartan—type 2 diabetes mellitus	4.51e-05	0.00026	CcSEcCtD
Rabeprazole—Anorexia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.00026	CcSEcCtD
Rabeprazole—Dizziness—Orlistat—type 2 diabetes mellitus	4.46e-05	0.000257	CcSEcCtD
Rabeprazole—Asthenia—Metformin—type 2 diabetes mellitus	4.46e-05	0.000257	CcSEcCtD
Rabeprazole—Hypotension—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000255	CcSEcCtD
Rabeprazole—Nausea—Gliclazide—type 2 diabetes mellitus	4.41e-05	0.000254	CcSEcCtD
Rabeprazole—Pruritus—Metformin—type 2 diabetes mellitus	4.4e-05	0.000254	CcSEcCtD
Rabeprazole—Urticaria—Losartan—type 2 diabetes mellitus	4.38e-05	0.000253	CcSEcCtD
Rabeprazole—Body temperature increased—Losartan—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Rabeprazole—Abdominal pain—Losartan—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Rabeprazole—Vomiting—Valsartan—type 2 diabetes mellitus	4.34e-05	0.00025	CcSEcCtD
Rabeprazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000249	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000249	CcSEcCtD
Rabeprazole—Rash—Valsartan—type 2 diabetes mellitus	4.3e-05	0.000248	CcSEcCtD
Rabeprazole—Dermatitis—Valsartan—type 2 diabetes mellitus	4.3e-05	0.000248	CcSEcCtD
Rabeprazole—Vomiting—Orlistat—type 2 diabetes mellitus	4.29e-05	0.000247	CcSEcCtD
Rabeprazole—Insomnia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000247	CcSEcCtD
Rabeprazole—Headache—Valsartan—type 2 diabetes mellitus	4.27e-05	0.000247	CcSEcCtD
Rabeprazole—Diarrhoea—Metformin—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Rabeprazole—Rash—Orlistat—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Rabeprazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Rabeprazole—Dermatitis—Orlistat—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Rabeprazole—Headache—Orlistat—type 2 diabetes mellitus	4.22e-05	0.000244	CcSEcCtD
Rabeprazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000243	CcSEcCtD
Rabeprazole—Asthenia—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000243	CcSEcCtD
Rabeprazole—Somnolence—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000243	CcSEcCtD
Rabeprazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.16e-05	0.00024	CcSEcCtD
Rabeprazole—Pruritus—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000239	CcSEcCtD
Rabeprazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000237	CcSEcCtD
Rabeprazole—Dizziness—Metformin—type 2 diabetes mellitus	4.11e-05	0.000237	CcSEcCtD
Rabeprazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.06e-05	0.000235	CcSEcCtD
Rabeprazole—Nausea—Valsartan—type 2 diabetes mellitus	4.05e-05	0.000234	CcSEcCtD
Rabeprazole—Constipation—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000233	CcSEcCtD
Rabeprazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000231	CcSEcCtD
Rabeprazole—Nausea—Orlistat—type 2 diabetes mellitus	4e-05	0.000231	CcSEcCtD
Rabeprazole—Asthenia—Losartan—type 2 diabetes mellitus	3.96e-05	0.000228	CcSEcCtD
Rabeprazole—Vomiting—Metformin—type 2 diabetes mellitus	3.95e-05	0.000228	CcSEcCtD
Rabeprazole—Rash—Metformin—type 2 diabetes mellitus	3.92e-05	0.000226	CcSEcCtD
Rabeprazole—Dermatitis—Metformin—type 2 diabetes mellitus	3.91e-05	0.000226	CcSEcCtD
Rabeprazole—Pruritus—Losartan—type 2 diabetes mellitus	3.9e-05	0.000225	CcSEcCtD
Rabeprazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000225	CcSEcCtD
Rabeprazole—Headache—Metformin—type 2 diabetes mellitus	3.89e-05	0.000225	CcSEcCtD
Rabeprazole—Dizziness—Irbesartan—type 2 diabetes mellitus	3.88e-05	0.000224	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000223	CcSEcCtD
Rabeprazole—Diarrhoea—Losartan—type 2 diabetes mellitus	3.77e-05	0.000218	CcSEcCtD
Rabeprazole—Urticaria—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000217	CcSEcCtD
Rabeprazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000216	CcSEcCtD
Rabeprazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000216	CcSEcCtD
Rabeprazole—Vomiting—Irbesartan—type 2 diabetes mellitus	3.73e-05	0.000215	CcSEcCtD
Rabeprazole—Rash—Irbesartan—type 2 diabetes mellitus	3.7e-05	0.000213	CcSEcCtD
Rabeprazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000213	CcSEcCtD
Rabeprazole—Nausea—Metformin—type 2 diabetes mellitus	3.69e-05	0.000213	CcSEcCtD
Rabeprazole—Headache—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000212	CcSEcCtD
Rabeprazole—Dizziness—Losartan—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Rabeprazole—Vomiting—Losartan—type 2 diabetes mellitus	3.51e-05	0.000202	CcSEcCtD
Rabeprazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000201	CcSEcCtD
Rabeprazole—Nausea—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000201	CcSEcCtD
Rabeprazole—Rash—Losartan—type 2 diabetes mellitus	3.48e-05	0.000201	CcSEcCtD
Rabeprazole—Dermatitis—Losartan—type 2 diabetes mellitus	3.48e-05	0.0002	CcSEcCtD
Rabeprazole—Headache—Losartan—type 2 diabetes mellitus	3.46e-05	0.000199	CcSEcCtD
Rabeprazole—Asthenia—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000196	CcSEcCtD
Rabeprazole—Pruritus—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000193	CcSEcCtD
Rabeprazole—Nausea—Losartan—type 2 diabetes mellitus	3.28e-05	0.000189	CcSEcCtD
Rabeprazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000187	CcSEcCtD
Rabeprazole—Dizziness—Ramipril—type 2 diabetes mellitus	3.13e-05	0.00018	CcSEcCtD
Rabeprazole—Vomiting—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000174	CcSEcCtD
Rabeprazole—Rash—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000172	CcSEcCtD
Rabeprazole—Dermatitis—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000172	CcSEcCtD
Rabeprazole—Headache—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000171	CcSEcCtD
Rabeprazole—Nausea—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000162	CcSEcCtD
Rabeprazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.48e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.48e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.48e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.47e-06	7.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.45e-06	7.95e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	5.42e-06	7.91e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.42e-06	7.91e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.39e-06	7.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.38e-06	7.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.3e-06	7.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	5.26e-06	7.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.16e-06	7.52e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.08e-06	7.41e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.08e-06	7.41e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.08e-06	7.41e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.05e-06	7.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.05e-06	7.37e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.05e-06	7.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	5.05e-06	7.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.04e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.04e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.04e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.03e-06	7.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	5.02e-06	7.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5e-06	7.29e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5e-06	7.29e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.99e-06	7.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	4.96e-06	7.23e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.96e-06	7.23e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.95e-06	7.22e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.94e-06	7.21e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.93e-06	7.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.93e-06	7.19e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.9e-06	7.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.87e-06	7.11e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.86e-06	7.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.85e-06	7.07e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.84e-06	7.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.83e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.83e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.83e-06	7.04e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	4.81e-06	7.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.8e-06	7.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.8e-06	7e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.8e-06	7e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.8e-06	7e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.8e-06	7e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.79e-06	6.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.79e-06	6.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.77e-06	6.96e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.69e-06	6.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	4.68e-06	6.83e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.66e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.66e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.66e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.66e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.65e-06	6.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.63e-06	6.76e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.61e-06	6.72e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.6e-06	6.71e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.6e-06	6.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	4.59e-06	6.7e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.56e-06	6.65e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.56e-06	6.65e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.5e-06	6.56e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.48e-06	6.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	4.48e-06	6.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.47e-06	6.52e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	4.46e-06	6.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.44e-06	6.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.42e-06	6.45e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	6.43e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	6.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.37e-06	6.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.37e-06	6.37e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	4.37e-06	6.37e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.32e-06	6.3e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.31e-06	6.29e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.31e-06	6.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.31e-06	6.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.31e-06	6.28e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.26e-06	6.22e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	4.26e-06	6.22e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.23e-06	6.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.19e-06	6.11e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.16e-06	6.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	4.14e-06	6.03e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.13e-06	6.03e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.13e-06	6.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.13e-06	6.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.11e-06	6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.1e-06	5.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	4.06e-06	5.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.06e-06	5.92e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.94e-06	5.75e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.94e-06	5.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	3.93e-06	5.73e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.9e-06	5.69e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-06	5.68e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.88e-06	5.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	3.86e-06	5.64e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	3.85e-06	5.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.83e-06	5.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	3.81e-06	5.55e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.8e-06	5.55e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.8e-06	5.55e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-06	5.54e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-06	5.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.8e-06	5.54e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.78e-06	5.52e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.78e-06	5.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.77e-06	5.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.77e-06	5.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.76e-06	5.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.75e-06	5.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	5.45e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	5.45e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.73e-06	5.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.73e-06	5.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.7e-06	5.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.7e-06	5.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.7e-06	5.4e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.7e-06	5.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.68e-06	5.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.68e-06	5.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.67e-06	5.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.62e-06	5.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.62e-06	5.28e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.59e-06	5.24e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.57e-06	5.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.57e-06	5.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.53e-06	5.15e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.52e-06	5.14e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.49e-06	5.1e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	5.04e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.43e-06	5e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	4.94e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.39e-06	4.94e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.37e-06	4.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.36e-06	4.9e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	3.35e-06	4.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.34e-06	4.88e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.32e-06	4.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.32e-06	4.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.32e-06	4.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.32e-06	4.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	3.29e-06	4.8e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	4.79e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.26e-06	4.76e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.26e-06	4.75e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.24e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.23e-06	4.72e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.22e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.22e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.22e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.22e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	4.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.16e-06	4.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.16e-06	4.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	4.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.15e-06	4.6e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.12e-06	4.54e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.11e-06	4.54e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.09e-06	4.5e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.07e-06	4.48e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.05e-06	4.46e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.04e-06	4.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.03e-06	4.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	3.02e-06	4.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.01e-06	4.38e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.01e-06	4.38e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-06	4.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	4.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.93e-06	4.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	4.27e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	4.24e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	4.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.89e-06	4.21e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.89e-06	4.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.88e-06	4.21e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.88e-06	4.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.88e-06	4.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.87e-06	4.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.87e-06	4.18e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	4.18e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.86e-06	4.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.84e-06	4.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	4.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.74e-06	4e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.69e-06	3.93e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.64e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.64e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.59e-06	3.78e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.52e-06	3.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.51e-06	3.66e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.5e-06	3.65e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.48e-06	3.62e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.48e-06	3.62e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.47e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	3.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	3.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.46e-06	3.58e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.45e-06	3.58e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.44e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.43e-06	3.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.37e-06	3.45e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	3.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	3.44e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.3e-06	3.36e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.26e-06	3.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.25e-06	3.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.21e-06	3.23e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.21e-06	3.22e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	3.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	3.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.15e-06	3.14e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.15e-06	3.14e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.15e-06	3.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	3.12e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.12e-06	3.09e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	3.06e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.04e-06	2.97e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2e-06	2.91e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	2.9e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.97e-06	2.87e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.96e-06	2.86e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.93e-06	2.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	2.81e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.9e-06	2.77e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.9e-06	2.76e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.87e-06	2.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	2.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	2.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	2.45e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.65e-06	2.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.62e-06	2.36e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	2.17e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	2.07e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	2.07e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	1.93e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.3e-06	1.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	1.58e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.98e-07	1.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.9e-07	1.44e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.46e-07	1.23e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.53e-07	9.52e-06	CbGpPWpGaD
